Adaptive dose selection paves the way for the second part of Mont Blanc Phase 3 trial, and the start of the second Phase 3 trial, Denali September 2, 2020 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today….